Clinical Trials Logo

Headache clinical trials

View clinical trials related to Headache.

Filter by:

NCT ID: NCT06383429 Completed - Neck Pain Clinical Trials

Relation Between Forward Head Posture and Incidence of Headache in Obese Adults

Start date: January 1, 2024
Phase:
Study type: Observational

Cross sectional study to detect relation between forward head posture and headache. We will take information from the patient about: - Detailed history of patient - Forward head posture by using mobile application - Headache disability index

NCT ID: NCT06383416 Completed - Clinical trials for Geriatric Patients With Neck Pain

Incidence of Headache and Its Effect on Quality of Life in Geriatric Patients With Chronic Neck Pain

Start date: January 21, 2024
Phase:
Study type: Observational

cross sectional study to detect the incidence of headache and its effect on quality of life in geriatric patients with chronic neck pain. Patients will fill out quality of life questionnaire and headache disability index. We will take information from the patients about: - The frequency of headache occurrence. - Visual analogue scale of chronic neck pain. Main measures: chronic neck pain will be assessed by visual analogue scale. Patients will fill out quality of life questionnaire and headache disability index.

NCT ID: NCT06380764 Completed - Clinical trials for Postdural Puncture Headache

Greater Occipital Nerve Block Value in Management of Postdural Puncture Headache

Start date: March 2, 2023
Phase: N/A
Study type: Interventional

Neuraxial techniques are well tolerated and effective options for labor analgesia and anesthesia for caesarean section, and may protect high risk women against severe maternal morbidity. However, neuraxial techniques still have drawbacks especially postdural puncture headache (PDPH) and may be associated with chronic headache, back pain and postnatal depression. PDPH is a relatively common acute complication of neuraxial techniques that was traditionally considered benign and self-limiting, but it significantly impacts patients' general health and quality of life. Greater Occipital Nerve (GON) originates from C2-3 segments and through its muscular relations it is divided as proximal and distal parts; the most proximal part lies between obliquus capitis inferior and semispinalis and then passes through the semispinalis to pierce the trapezius muscle. In distal region of trapezius fascia, the GON is crossed by the occipital artery and exits the trapezius fascia into the nuchal line about 5-cm lateral to midline. Functionally, GON provides motor supplies to the muscles while passing through it and its main sensory supply is in the occipital region.

NCT ID: NCT06377787 Not yet recruiting - Clinical trials for Cervicogenic Headache

Effects of ELDOA in Patients With Cervicogenic Headache

Start date: April 2024
Phase: N/A
Study type: Interventional

The aim of our study is to determine the effect of ELDOA in relieving pain, improving ROM and functional disability in patients with cervicogenic headache. This study will add to the growing body of knowledge that if this technique yields comparable outcomes, it would be the alternative therapy. Moreover, it would add to the society as no literature is available on the effect of ELDOA technique in the management of Cervicogenic headache.

NCT ID: NCT06366139 Completed - Clinical trials for Trigeminal Neuralgia

Trigeminal Ganglion RFT vs Maxillary/Mandibular PRF in the Treatment of Trigeminal Neuralgia

Start date: January 11, 2023
Phase: N/A
Study type: Interventional

Trigeminal ganglion (TG) radiofrequency thermocoagulation (RFT) and ultrasound (US)-guided maxillary or mandibular (max/mand) pulsed radiofrequency (PRF) are two interventional procedures for the treatment of trigeminal neuralgia (TN). The aim of this study was to compare the efficacy and safety of these two procedures. For this evaluation, the numeric rating scale (NRS) was used to assess pain relief and the Medication Quantification Scale III (MQS III) was used to assess the effectiveness of the interventions on medication consumption. The rates of adverse events related to the interventions were also compared.

NCT ID: NCT06342232 Completed - Migraine Headaches Clinical Trials

The Efficacy of Neurofeedback Mindfulness in Migraine Management

Start date: September 9, 2021
Phase: N/A
Study type: Interventional

This longitudinal randomized controlled trial explored how long-term practice of neurofeedback mindfulness would be helpful for migraine management when compare dot a similar controlled intervention. All the participants went through assigned 10 minutes practices on a daily basis for 8 weeks. Behavioural reports and migraine characteristics were compared before and after the intervention.

NCT ID: NCT06342219 Not yet recruiting - Clinical trials for Chronic Migraine, Headache

Chronic Migraines and Neurofdeeback Mindfulness

Start date: December 2024
Phase: N/A
Study type: Interventional

As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.

NCT ID: NCT06323720 Recruiting - Clinical trials for Tension-Type Headache

Signs of Central Sensitization in Tension-type Headache

CSTTH
Start date: February 23, 2024
Phase:
Study type: Observational

The goal of this observational study is to assess the pain sensitivity in tension-type headache patients. The main question it aims to answer is: - Are signs of central sensitization present in tension-type headache? Participants will be asked to fill out baseline questionnaires and they will be assessed during 1 test moment (static and dynamic quantitative sensory testing). Researchers will compare tension-type headache patients with healthy controls to see if signs of central sensitization are only present in the tension-type headache group.

NCT ID: NCT06310200 Not yet recruiting - Headache Clinical Trials

Sphenopalatine Ganglion Block and Cold Induced Headaches

Start date: April 1, 2024
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to determine if a sphenopalatine ganglion (SPG) block, performed through intranasal atomization of 4% lidocaine, is able to prevent cold induced cephalgia ("Brain Freeze"). Secondary objectives will be to determine the degree of decreased pain/duration of brain freeze after sphenopalatine ganglion block

NCT ID: NCT06295003 Completed - COVID-19 Clinical Trials

Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department

Start date: April 30, 2022
Phase:
Study type: Observational

Background: To evaluate the impact of COVID-19 on evaluations in the pediatric emergency department (ED) because of headache as main symptom. Methods: Number and clinical features of patients evaluated in the pediatric ED of a single site in Milan,Italy, were collected between January 2017 and January 2022. The impact of COVID-19 on evaluation rates was quantified by using the incidence rate ratio (IRR) and 95% confidence intervals (CI) between the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).